Circulating Protein Biomarkers Correlate with Future Risk of Dementia – Fight Aging!

Researchers have developed a predictive biomarker panel for Alzheimer’s disease risk based on protein levels in a blood sample, representing one of several similar tests developed in recent years. The question remains: what actions should one take in response to a high risk measurement for Alzheimer’s disease? Currently, the primary option is to generally improve lifestyle choices, but Alzheimer’s disease is not as strongly correlated with lifestyle factors as other conditions like type 2 diabetes. One potential action based on the link between senescent cells and neurodegeneration is to intermittently take senolytic drugs, and there is also evidence to support the use of antiviral drugs due to the role of persistent viral infection in the development of Alzheimer’s disease. However, other options are currently limited.